US Broker Ratings

TransMedics Group, Inc. (TMDX) Stock Analysis: A 21.55% Potential Upside in the Healthcare Sector

TransMedics Group, Inc. (NASDAQ: TMDX) is a pioneering player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $4.45 billion,..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Lucrative 6.74% Upside Amidst Robust Revenue Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a leading player in the medical devices sector, presents an intriguing opportunity for investors seeking exposure to the healthcare..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 22.47% Potential Upside in the Medical Devices Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) presents an intriguing opportunity for investors within the healthcare sector, specifically in the field of medical devices. With a market..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 9.59% Upside with Solid Dividend Yields

Takeda Pharmaceutical Company Limited (NYSE: TAK), a venerable giant in the healthcare sector, stands out with its impressive $56.49 billion market capitalization. Headquartered in Tokyo, Japan,..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 50.91% Upside Potential Awaits Investors

Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical innovator in the biotechnology industry, is making waves with its cutting-edge treatments targeting muscle function. With a market cap of..

Atrium Therapeutics (RNA) Stock Report: Navigating the Biotech Sector with a Market Cap of $229.93 Million

Atrium Therapeutics, Inc. (RNA) is carving its niche in the dynamic biotechnology sector, with a particular focus on RNA therapeutics aimed at treating cardiomyopathies. Headquartered in..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 39.64% Potential Upside in Healthcare Innovation

Bio-Techne Corp (NASDAQ: TECH) is a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $8.43 billion and a..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Capitalizing on a 49.91% Potential Upside with Groundbreaking Biopharma Innovations

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical firm, is capturing significant attention in the biotechnology sector due to its pioneering focus on rare neuroendocrine diseases...

Glaukos Corporation (GKOS) Stock Analysis: Understanding the 25% Potential Upside

Glaukos Corporation (NYSE: GKOS), a leader in the medical devices sector with a focus on ophthalmic pharmaceuticals and medical technology, has been making waves in the..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring an 83.84% Potential Upside in Biotech Innovation

Vaxcyte, Inc. (NASDAQ: PCVX) is capturing investor attention with its remarkable potential upside of 83.84%, as evidenced by the average analyst target price of $109, compared..

Haleon plc (HLN) Stock Analysis: Navigating a 16.03% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a pivotal player in the healthcare sector, presents a compelling investment opportunity with a notable potential upside of 16.03%, according to the latest..

Quest Diagnostics (DGX) Stock Analysis: Unlocking a 9.68% Potential Upside in Healthcare Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth prospects...

Lantheus Holdings, Inc. (LNTH)

⚠️ No article content returned.

..

Alcon Inc. (ALC) Investor Outlook: Exploring a 15.94% Potential Upside in the Eye Care Giant

For investors seeking opportunities in the healthcare sector, Alcon Inc. (NYSE: ALC) presents a compelling case. With a significant market cap of $40.65 billion, this Swiss-based..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Potential Upside Shines Amid Analyst Confidence

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out as a noteworthy player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating a 20% Upside Potential Amidst Stable Revenue Growth

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, particularly in the medical devices industry, is drawing attention from investors due to its..

Option Care Health, Inc. (OPCH) Stock Analysis: Strong Buy Ratings Point to 34% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH), a leader in the healthcare sector specializing in home and alternate site infusion services, is capturing investor attention with its..

BrightSpring Health Services, I (BTSG): Investor Outlook Reveals Potential 22.92% Upside

BrightSpring Health Services, Inc. (BTSG) stands as a notable player in the healthcare sector, specifically within the health information services industry. Headquartered in Louisville, Kentucky, this..

Chemed Corp (CHE) Stock Analysis: Is the 8.61% Potential Upside Worth Your Investment?

Chemed Corp (NYSE: CHE), a key player in the healthcare sector, stands out with its diverse operations spanning hospice and palliative care services through its VITAS..

TG Therapeutics, Inc. (TGTX): Investor Outlook with a Promising 51.79% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is capturing investor attention with its significant potential upside of 51.79% and a robust market cap of $4.67 billion. Based in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds